Tilal Elsaman, Ali Mahmoud Muddathir, Ebtihal A M Mohieldin, Irmanida Batubara, Min Rahminiwati, Kosei Yamauchi, Magdi Awadalla Mohamed, Shadila Fira Asoka, Dietrich Büsselberg, Solomon Habtemariam, Javad Sharifi-Rad
Cancer remains one of the leading causes of death in the world. Despite the considerable success of conventional treatment strategies, the incidence and mortality rates are still high, making developing new effective anticancer therapies an urgent priority. Ginsenoside Rg5 (Rg5) is a minor ginsenoside constituent obtained exclusively from ginseng species and is known for its broad spectrum of pharmacological activities. This article aimed to comprehensively review the anticancer properties of Rg5, focusing on action mechanisms, structure-activity relationship (SAR), and pharmacokinetics attributes...
March 25, 2024: Pharmacological Reports: PR